Optima Capital »

Leap Therapeutics shares owned by Optima Capital

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Optima Capital from 13F filings

Historical chart of Optima Capital investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Optima Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Optima Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $925 798 1.16

More positions owned by Optima Capital

Spdr Series Trust State Street Spd (SPYM)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Income Etf (JPIE)
Doubleline Etf Trust Opportunistic Co (DBND)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Core Msci Eafe (IEFA)
Cambria Etf Tr Global Value Etf (GVAL)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Ishares Tr Msci Usa Quality (GARP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Vanguard Specialized Funds Div App Etf (VIG)
Wisdomtree Tr Wisdomtree Us Va (WTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)

View all positions for Optima Capital

Top funds holding Leap Therapeutics

Gilead Sciences
Vanguard Group
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
State Street Corporation
BlackRock
Hrt Financial
Texas Capital Bank Wealth Management Services
Two Sigma Advisers
Susquehanna International
Key Client Fiduciary Advisors
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics